how to get access to glp 1 New Medicare GLP-1 Bridge Program Launching July 1, 2026 CMS Expands Access to GLP-1

In the ELIXA study, 6,068 patients with T2D who had an MI or who had been hospitalized for unstable angina within the previous 180 days were randomized to receive lixisenatide or placebo in addition to baseline treatment

Many qualify as ultra-processed foods containing: If a company markets such products as promoting metabolic health or weight control, it may cross the line from permissible advertising into false or deceptive marketing practices

How do we manage costs

Studies directly characterizing the effects of treatment with tirzepatide in patients with T2D and/or obesity and COVID-19 or long COVID have not been published yet

Science (New York, NY)

Preliminary results from clinical trials indicate that Orforglipron could become a breakthrough in the segment of oral substances supporting research on people battling obesity and type 2 diabetes